31 related articles for article (PubMed ID: 8864439)
1. Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas.
Kasamon YL; Jones RJ; Gocke CD; Blackford AL; Seifter EJ; Davis-Sproul JM; Gore SD; Ambinder RF
Biol Blood Marrow Transplant; 2011 Mar; 17(3):365-73. PubMed ID: 20655387
[TBL] [Abstract][Full Text] [Related]
2. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
3. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
van Besien K; Margolin K; Champlin R; Forman S
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
[TBL] [Abstract][Full Text] [Related]
4. High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma.
Blystad A; Kvalheim G; Torlakovic E; Holte H; Jacobsen E; Beiske K; Vâlerhaugen H; Lenschow E; Kvaloy S
Bone Marrow Transplant; 1999 Oct; 24(8):865-72. PubMed ID: 10516698
[TBL] [Abstract][Full Text] [Related]
5. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
[TBL] [Abstract][Full Text] [Related]
6. Autologous bone marrow transplantation for non-transformed low-grade non-Hodgkin's lymphoma.
Cervantes F; Shu XO; McGlave PB; Ramsay NK; Miller WJ; Kersey JH; Weisdorf DJ
Bone Marrow Transplant; 1995 Sep; 16(3):387-92. PubMed ID: 8535311
[TBL] [Abstract][Full Text] [Related]
7. 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement.
Bird JM; Luger S; Mangan P; Edelstein M; Silberstein L; Powlis W; Ball J; Schultz DJ; Stadtmauer EA
Bone Marrow Transplant; 1996 Aug; 18(2):309-13. PubMed ID: 8864439
[TBL] [Abstract][Full Text] [Related]
8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
9. Purging with 4-hydroperoxycyclophosphamide.
Jones RJ
J Hematother; 1992; 1(4):343-8. PubMed ID: 1345676
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow transplantation for patients with aggressive non-Hodgkin's lymphoma.
Armitage JO
Bone Marrow Transplant; 1992; 10 Suppl 1():62-3. PubMed ID: 1521093
[No Abstract] [Full Text] [Related]
11. Purging of autologous bone marrow in the treatment of non-Hodgkin's lymphoma.
Gribben JG; Nadler LM
Important Adv Oncol; 1993; ():139-56. PubMed ID: 8505048
[No Abstract] [Full Text] [Related]
12. Bone marrow transplantation for non-Hodgkin's lymphoma: a review.
Salzman DE; Briggs AD; Vaughan WP
Am J Med Sci; 1997 Apr; 313(4):228-35. PubMed ID: 9099153
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]